Assembly Biosciences, Inc. Common Stock ASMB
i
Market dataready · fetched 2026-11-03T18:46:06.988Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T18:45:57.769544677Z
FundamentalsSEC EDGAR · ready · as of 2026-06-30 · fetched 2026-11-03T18:46:06.101559+00:00
Assembly Biosciences, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | ||||||
| 50Δ | ||||||
| 55Δ | 19.76 | 73.7% | 6.3% | |||
| 60Δ | 19.32 | 74.0% | 5.5% | |||
| 65Δ | 18.89 | 74.2% | 4.6% | |||
| 70Δ | 18.46 | 74.5% | 3.8% | |||
| 75Δ | 18.02 | 74.8% | 3.0% | 23.16 | 88.1% | 2.5% |
| 80Δ | 17.59 | 75.0% | 2.2% | 23.83 | 85.5% | 1.8% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 19.76
- IV
- 73.7%
- B/E move
- 6.3%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 19.32
- IV
- 74.0%
- B/E move
- 5.5%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 18.89
- IV
- 74.2%
- B/E move
- 4.6%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 18.46
- IV
- 74.5%
- B/E move
- 3.8%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 18.02
- IV
- 74.8%
- B/E move
- 3.0%
- Pseudo strike
- 23.16
- IV
- 88.1%
- B/E move
- 2.5%
80Δ
- Pseudo strike
- 17.59
- IV
- 75.0%
- B/E move
- 2.2%
- Pseudo strike
- 23.83
- IV
- 85.5%
- B/E move
- 1.8%
Options history
Table
| Date | IV (%) |
|---|---|
| 81.10% | |
| 82.92% | |
| 85.93% | |
| 89.33% | |
| 86.43% | |
| 86.83% | |
| 89.79% | |
| 90.73% | |
| 89.98% | |
| 86.91% |
Biotechnology
ASND
Description unavailable
More →ATNM
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation (BMT) or a type of…
More →ATOS
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered…
More →AUPH
Description unavailable
More →AURA
Description unavailable
More →AUTL
Description unavailable
More →